Prognostic Value of Complement Component 2 and Its Correlation with Immune Infiltrates in Hepatocellular Carcinoma

Table 3

Univariate and multivariate analysis of C2 expression for overall survival in HCC patients of the GSE14520 cohort.

Variables	Univariate analysis			Multivariate analysis
	Hazard ratio	95% CI	value	Hazard ratio	95% CI	value
Gender (male vs. female)	1.68	0.81-3.49	0.16
Age (>50 vs. ≤50)	1.0	0.65-1.53	0.99
Cirrhosis (yes vs. no)	4.57	1.13-18.62	0.03	3.66	0.89-14.98	0.07
Main tumor size (>5 cm vs. ≤5 cm)	1.97	1.28-3.30	0.002	1.18	0.69-2.01	0.56
TNM stage (III+IV vs. I+II)	3.43	2.20-6.11	0.000	2.38	1.64-3.46	0.000
C2 (high vs. low)	0.56	0.36-0.87	0.01	0.73	0.47-1.16	0.18